Clinical Trial Update: Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of Ragweed Mix administered by intralymphatic node injections for allergic conjunctivitis and allergic rhinitis was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Ragweed Mix

Snippet

Sponsor: Woodmont Pharmaceuticals, Inc. | Conditions: Allergic Conjunctivitis, Allergic Rhinitis | Phase 1 | Status: TERMINATED